116 related articles for article (PubMed ID: 30182347)
41. Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.
Hudson CA; Burack WR; Bennett JM
Leuk Res; 2018 Oct; 73():12-15. PubMed ID: 30176385
[TBL] [Abstract][Full Text] [Related]
42. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
Parikh SA; Tefferi A
Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
[TBL] [Abstract][Full Text] [Related]
43. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller S; Stauder R; Kuehr T; Lang A; Machherndl-Spandl S; Mayrbaeurl B; Noesslinger T; Petzer A; Valent P; Greil R; Thaler J
Leuk Lymphoma; 2018 May; 59(5):1121-1126. PubMed ID: 28853315
[TBL] [Abstract][Full Text] [Related]
44. Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia.
Robak T; Urbańska-Ryś H; Smolewski P; Wawrzyniak E; Korycka A; Kordek R; Bartkowiak J
Leuk Lymphoma; 2003 Nov; 44(11):2001-8. PubMed ID: 14738156
[TBL] [Abstract][Full Text] [Related]
45. Clinical and hematological aspects of chronic myelomonocytic leukemia. Study on 20 cases from a single center from Romania.
Gologan R; Berceanu A; Colita A; Codreanu V; Dobrea C; Geoada L; Iacob V; Niculescu-Mizil E; Ostroveanu D; Puşcariu T; Ursuleac I
Rom J Intern Med; 2002; 40(1-4):95-102. PubMed ID: 15526545
[TBL] [Abstract][Full Text] [Related]
46. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.
Crişan AM; BădeliŢă SN; Jardan C; Vasilache ED; Dobrea CM; Gheorghe A; Tălmaci R; Arion CV; Bardaş A; Găman AM; Coriu D
Rom J Morphol Embryol; 2015; 56(3):1145-51. PubMed ID: 26662151
[TBL] [Abstract][Full Text] [Related]
47. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
48. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
[TBL] [Abstract][Full Text] [Related]
49. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
50. CMML: Clinical and molecular aspects.
Itzykson R; Duchmann M; Lucas N; Solary E
Int J Hematol; 2017 Jun; 105(6):711-719. PubMed ID: 28455647
[TBL] [Abstract][Full Text] [Related]
51. Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
Bhattacharyya PK
Indian J Pathol Microbiol; 2013; 56(3):188-9. PubMed ID: 24152491
[TBL] [Abstract][Full Text] [Related]
52. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.
Itonaga H; Iwanaga M; Aoki K; Aoki J; Ishiyama K; Ishikawa T; Sakura T; Fukuda T; Najima Y; Yujiri T; Mori T; Kurokawa M; Nawa Y; Uchida N; Morishita Y; Hashimoto H; Eto T; Hirokawa M; Morishima Y; Nagamura-Inoue T; Atsuta Y; Miyazaki Y
Leuk Res; 2016 Feb; 41():48-55. PubMed ID: 26754557
[TBL] [Abstract][Full Text] [Related]
53. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
[TBL] [Abstract][Full Text] [Related]
54. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
Kvasnicka HM
Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
[TBL] [Abstract][Full Text] [Related]
55. A case report: Concurrent chronic myelomonocytic leukemia and T-cell large granular lymphocytic leukemia-type clonal proliferation as detected by multiparametric flow cytometry.
Song S
Cytometry B Clin Cytom; 2011 Mar; 80(2):126-9. PubMed ID: 21337493
[TBL] [Abstract][Full Text] [Related]
56. Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
Harel S; Cherait A; Berthon C; Willekens C; Park S; Rigal M; Brechignac S; Thépot S; Quesnel B; Gardin C; Adès L; Fenaux P; Braun T
Leuk Res; 2015 May; 39(5):501-4. PubMed ID: 25735917
[TBL] [Abstract][Full Text] [Related]
57. Models of Prognostication in Chronic Myelomonocytic Leukemia.
Onida F
Curr Hematol Malig Rep; 2017 Dec; 12(6):513-521. PubMed ID: 29064026
[TBL] [Abstract][Full Text] [Related]
58. Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience.
Subari S; Patnaik M; Alfakara D; Gangat N; Elliott M; Hogan W; Litzow M; Al-Kali A
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):546-9. PubMed ID: 26189785
[TBL] [Abstract][Full Text] [Related]
59. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems.
Breccia M; Cannella L; Frustaci A; Stefanizzi C; D'Elia GM; Alimena G
Leuk Lymphoma; 2008 Jul; 49(7):1292-6. PubMed ID: 18604717
[TBL] [Abstract][Full Text] [Related]
60. Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia.
Nazha A; Patnaik MM
Curr Hematol Malig Rep; 2018 Oct; 13(5):341-347. PubMed ID: 30066099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
